Hospira wins cancer care drug patent fight with Sanofi
WILMINGTON, Del. -- A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere.
The judge ruled Monday that the claims asserted by the world's third-largest pharmaceutical company involving Taxotere were both invalid and unenforceable.
The ruling comes almost a year after a trial in a lawsuit filed by Sanofi against Hospira Inc. of Lake Forest, and Toronto's Apotex Corp. which sought to make generic versions of the drug. Taxotere is used to treat breast cancer and prostate cancer, among others.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.